No effects of COVID-19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS-CoV-2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects

AIMS: To evaluate the relationship between SARS-CoV-2 infection and autoimmunity in type 1 diabetes (T1D) and SARS-CoV-2 antibodies frequency at diagnosis of T1D during pandemic. METHODS: The presence of T1D-specific autoimmunity was evaluated in a cohort of 99 children and adolescents without diabe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiberti, Claudio, Nenna, Raffaella, Tromba, Valeria, Filardi, Tiziana, Petrarca, Laura, Silvestri, Francesca, Fassino, Valeria, Montuori, Monica, Mancino, Enrica, Lenzi, Andrea, Midulla, Fabio, Costantino, Francesco, Morano, Susanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175916/
https://www.ncbi.nlm.nih.gov/pubmed/37171699
http://dx.doi.org/10.1007/s00592-023-02103-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175916/
https://www.ncbi.nlm.nih.gov/pubmed/37171699
http://dx.doi.org/10.1007/s00592-023-02103-1

Ejemplares similares